RGDV修飾ゲムシタビン：半減期を延長し、抵抗性を克服し、ゲムシタビンの骨髄毒性を排除できるナノ医薬品

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Molecular and cellular mechanisms of chemoresistance in pancreatic cancer2017 · 183 citations
2. 2Metformin suppresses tumor angiogenesis and enhances the chemosensitivity of gemcitabine in a genetically engineered mouse model of pancreatic cancer2018 · 46 citations
3. 3Gemcitabine anti-proliferative activity significantly enhanced upon conjugation with cell-penetrating peptides2017 · 34 citations
4. 4The influence of BIBW22BS, a dipyridamole derivative, on the antiproliferative effects of 5-fluorouracil, methotrexate and gemcitabine in vitro and in human tumour xenografts1995 · 23 citations
5. 5Poly (l-glutamic acid)-g-methoxy poly (ethylene glycol)-gemcitabine conjugate improves the anticancer efficacy of gemcitabine2018 · 14 citations